Cytomegalovirus (CMV) IgG ELISA Kit

  • Created on the 22 August, 2017.


Human CMV IgG ELISA kit is intended for analysing in-vitro quantitative levels of human IgG antibodies to cytomegalovirus (CMV) in plasma or serum samples. This assay has a minimum analytical sensitivity limit of 1.29 U/ml.


Cytomegalovirus (CMV) is a member of the herpes family of viruses and it can be spread by blood, saliva, urine, breast milk, vaginal fluids and semen. This means that some possible modes of transmission include blood transfusions, organ transplants, breastfeeding and sexual contact. If a person becomes infected then this virus can remain inactive within their body throughout their life. Infants which are born to mothers that are infected with CMV during pregnancy could develop congenital CMV infection. Individuals that have a weak immune system are prone to CMV causing serious diseases/illnesses such as hepatitis, pneumonia, retinitis, encephalitis or colitis). There is the possibility of antiviral treatments which could improve the prognosis in some patients with cytomegalovirus infections. However, currently there are no CMV vaccines that are commercially available. Some of the laboratory techniques that have been used to study this virus are CF and ELISA methods. Serologically either IgG or IgM antibodies can be determined and quantitated, as well as the avidity of the IgG molecules can be measured.


The minimum detection sensitivity level of cytomegalovirus IgG (CMV-IgG) using current human CMV IgG ELISA kit was 1.29 U/ml. The dynamic range for this assay is 1.0 – 90.0 U/ml.


  1. Performance of a cytomegalovirus IgG enzyme immunoassay kit modified to measure avidity. Clin Vaccine Immunol. (2014) 21 (6): 808-12. Prince H.E., et al.
  2. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples. J Clin Virol. (2006) 35 (3): 303-9. Dangel V., et al.
  3. Detection of human cytomegalovirus IgG antibody using automated immunoassay with recombinant antigens gives uniform results to established assays using whole virus antigens. Pathology. (2010) 42 (6): 578-80. Baalawi F., et al.
  4. Evaluation of a novel array-based toxoplasma, rubella, cytomegalovirus, and herpes simplex virus IgG enzyme linked immunosorbent assay and its comparison with virion/serion enzyme linked immunosorbent assays. Ann Lab Med. (2014) 34 (1): 38-42. Wu D., et al.
  5. IgG subclass antibodies to human cytomegalovirus (CMV) in normal human plasma samples and immune globulins and their neutralizing activities. Biologicals. (1996) 24 (2): 117-24. Gupta C.K., et al.


  • Full Name: Cytomegalovirus (CMV) IgG ELISA Kit
  • Reactivity: Human
  • Sample Type: Plasma, Serum
  • Sensitivity: 1.29 U/ml



Your secretory IgA ELISA kit gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA kit performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA kits from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA kits. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford